Transplants for myocardial scars
AssigneeGenzyme Corporation
InventorsDonald A. G. Mickle, Ren-Ke Li, Richard D. Weisel
Life of this patent
Estimating the term…
Abstract
A method is provided for forming a graft in heart tissue which comprises the transplantation of cells chosen from cardiomyocytes, fibroblasts, smooth muscle cells, endothelial cells and skeletal myoblasts. The grafts are especially useful in treating scar tissue on the heart.
Claims23
Isolated cells, said cells comprising at least one of the following cell types:
- adult cardiomyocytes;
- pediatric cardiomyocytes;
- adult fibroblasts;
- fetal fibroblasts;
- adult smooth muscle cells;
- fetal smooth muscle cells;
- endothelial cells;
- or
- skeletal myoblasts,
- wherein said cells survive in myocardial scar tissue after transplantation into said myocardial scar tissue, and wherein said cells improve cardiac function, relative to cardiac function of a heart having similar myocardial scar tissue that is not transplanted with said cells, wherein cardiac function is assessed by at least one of the criteria selected from the group consisting of:
- area occupied by said scar tissue;
- vascularization of said scar tissue;
- blood flow to said scar tissue;
- developed pressure;
- systolic pressure;
- end diastolic pressure;
- and .DELTA.Pressure/.DELTA.time.
A method of forming a stable cardiac graft in a mammal, said method comprising transplanting, into the scar tissue of a heart, cells comprising at least one of the following cell types:
- adult cardiomyocytes;
- pediatric cardiomyocytes;
- adult fibroblasts;
- fetal fibroblasts;
- adult smooth muscle cells;
- fetal smooth muscle cells;
- endothelial cells;
- or
- skeletal myoblasts,
- wherein said cells survive in scar tissue in a heart after transplantation into said scar tissue, and wherein said cells improve cardiac function, relative to cardiac function of a heart having similar myocardial scar tissue that is not transplanted with said cells, wherein cardiac function is assessed by at least one of the criteria selected from the group consisting of:
- area occupied by said scar tissue;
- vascularization of said scar tissue;
- blood flow to said scar tissue;
- developed pressure;
- systolic pressure;
- end diastolic pressure;
- and .DELTA.Pressure/.DELTA.time, wherein at least 10% of said scar tissue is occupied by transplanted cells four weeks after transplantation.
A method of treating defective, damaged or scarified heart tissue, said method comprising transplanting into said defective, damaged or scarified heart tissue a graft of cells, wherein said graft of cells comprises a combination of:
- adult cardiomyocytes and endothelial cells;
- pediatric cardiomyocytes and endothelial cells;
- or
- myoblasts and endothelial cells.
A therapeutic graft for implantation in mammalian myocardial tissue or scar tissue in a heart, said graft comprising biodegradable or non-biodegradable scaffolding supporting cells, wherein said cells comprise a combination of:
- adult cardiomyocytes and endothelial cells;
- pediatric cardiomyocytes and endothelial cells;
- or
- myoblasts and endothelial cells.
A therapeutic graft for use in scar tissue in a mammalian heart, said graft comprising transplanted cells, wherein said cells comprise:
- adult cardiomyocytes;
- adult fibroblasts;
- fetal fibroblasts;
- smooth muscle cells;
- endothelial cells;
- or
- skeletal myoblasts.
A therapeutic graft for use in myocardial tissue in a mammalian heart, said graft comprising transplanted cells, wherein said transplanted cells comprise:
- adult fibroblasts;
- fetal fibroblasts;
- smooth muscle cells;
- or
- endothelial cells.
A method of forming a stable myocardial graft in a mammal, said method comprising transplanting cells into myocardial tissue in the heart of said mammal, wherein said cells comprise:
- adult fibroblasts;
- fetal fibroblasts;
- smooth muscle cells;
- or
- endothelial cells.
A method of treating defective, damaged or scarified heart tissue, said method comprising transplanting, into said tissue, a graft of cells comprising:
- adult cardiomyocytes;
- adult fibroblasts;
- fetal fibroblasts;
- smooth muscle cells;
- endothelial cells;
- or
- skeletal myoblasts.
Dependencies are inferred from the claim text.